---
title: "TNGX.US (TNGX.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/TNGX.US/news.md"
symbol: "TNGX.US"
name: "TNGX.US"
parent: "https://longbridge.com/en/quote/TNGX.US.md"
datetime: "2026-05-21T01:43:12.743Z"
locales:
  - [en](https://longbridge.com/en/quote/TNGX.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/TNGX.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/TNGX.US/news.md)
---

# TNGX.US (TNGX.US) — Related News

### [Top 10 US Stock Losers (5.15)](https://longbridge.com/en/news/286620194.md)
*2026-05-15T22:00:51.000Z*
> POET Tech(POET) fell 22.36%, with a trading turnover 1.8 Billion USD, and a year-to-date rose 152.3%. Rackspace Tech(RXT

### [](https://longbridge.com/en/news/286595669.md)
*2026-05-15T16:21:21.000Z*
> Tango Therapeutics shares are trading lower after Piper Sandler downgraded its rating on the stock from Overweight to Ne

### [This Alumis Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday](https://longbridge.com/en/news/286566238.md)
*2026-05-15T12:28:45.000Z*
> Top analysts have downgraded several stocks, including Tango Therapeutics (from Overweight to Neutral), Viking Holdings 

### [Vanguard Group Inc. Has $59.81 Million Holdings in Tango Therapeutics, Inc. $TNGX](https://longbridge.com/en/news/286550878.md)
*2026-05-15T10:49:28.000Z*
> Vanguard Group Inc. increased its holdings in Tango Therapeutics, Inc. by 33.6% in Q4, owning 6,750,977 shares valued at

### [Tango Therapeutics, Inc. Stock 12‑Month Price Target Raised to $27.4, Implies 7% Upside](https://longbridge.com/en/news/286444484.md)
*2026-05-14T16:20:09.000Z*
> Tango Therapeutics, Inc. has seen its stock's average price target raised from $23.9 to $26, indicating a potential upsi

### [Tango Therapeutics | 10-Q: FY2026 Q1 Revenue Misses Estimate at USD 0](https://longbridge.com/en/news/286350666.md)
*2026-05-14T03:21:21.000Z*
### [Tango Therapeutics | 8-K: FY2026 Q1 Revenue Misses Estimate at USD 0](https://longbridge.com/en/news/286312013.md)
*2026-05-13T20:23:54.000Z*
### [Tango Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Highlights | TNGX Stock News](https://longbridge.com/en/news/286309850.md)
*2026-05-13T12:07:00.000Z*
> Tango Therapeutics reported its Q1 2026 financial results, highlighting a cash position of $380 million, sufficient to f